Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04411303 · ClinicalTrials.gov registry record · Phase 1
A Novel, Comprehensive Approach to Post-stroke Gait Rehabilitation
A Phase 1 study of CVA (Cerebrovascular Accident), sponsored by University of Southern California.
- Active
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT04411303: Active Phase 1 study of CVA (Cerebrovascular Accident), sponsored by University of Southern California.
NCT04411303 is a Phase 1 study of CVA (Cerebrovascular Accident) that is active but no longer recruiting, run by University of Southern California. The registered enrollment target is 50 participants, above the 31-participant average among 3 other CVA (Cerebrovascular Accident) trials with a reported enrollment target (61% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04411303, a Phase 1 study of CVA (Cerebrovascular Accident), is active but no longer recruiting, sponsored by University of Southern California.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to determine the feasibility and optimal parameters of a novel, comprehensive approach to gait training in individuals with chronic stroke. The comprehensive approach includes biofeedback-based gait training and aerobic exercise intensity-based gait training.
Primary Outcome
characterized as a comparison between the right and left legs of whole lower limb kinematics at heel strike; captured to quantify change in performance with biofeedback
Conditions Studied
Interventions
- BEHAVIORAL Step length biofeedback
- BEHAVIORAL Propulsive force biofeedback
- BEHAVIORAL Interlimb asymmetry biofeedback
- BEHAVIORAL Aerobic intensity-based walking
Study Locations (1)
California
- University of Southern California - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-06-09 |
| Est. Completion | 2025-12-14 |
| Phase | Phase 1 |
What the registry record for NCT04411303 still lists
NCT04411303 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, above the 31-participant average among 3 other CVA (Cerebrovascular Accident) trials with a reported enrollment target (61% higher).
The record links to 1 condition, with CVA (Cerebrovascular Accident) appearing as the primary indexed condition, and to 4 interventions - of which Step length biofeedback is the first listed.
NCT04411303 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04411303 about?
NCT04411303 is a clinical study titled "A Novel, Comprehensive Approach to Post-stroke Gait Rehabilitation". The goal of this project is to determine the feasibility and optimal parameters of a novel, comprehensive approach to gait training in individuals with chronic stroke. The comprehensive approach includes biofeedback-based gait training and aerobic exercise intensity-based gait training.
What is the current status of trial NCT04411303?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2021-06-09. Estimated completion is 2025-12-14.
What conditions does trial NCT04411303 study?
This clinical trial studies the following conditions: CVA (Cerebrovascular Accident).
What interventions are being tested in trial NCT04411303?
The interventions under investigation include: Step length biofeedback (BEHAVIORAL), Propulsive force biofeedback (BEHAVIORAL), Interlimb asymmetry biofeedback (BEHAVIORAL), Aerobic intensity-based walking (BEHAVIORAL).
Who is sponsoring clinical trial NCT04411303?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04411303 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for CVA (Cerebrovascular Accident)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI